https://www.selleckchem.com/pr....oducts/ch5183284-deb
87% with a 40 μg/mL CHSP treatment. Consistent with our previous reports, CHSP inhibits vascular endothelial growth factor (VEGF) secretion by regulating the HIF-1α-VEGF pathway. In addition, we also found that the inhibitory effect of CHSP on ovarian cancer is related to the up-regulation of Phosphatase and tension homolog (PTEN) and down-regulation of nuclear factor kappa-B (NF-kappa . These findings provide some evidence of the anti-ovarian cancer properties of CHSP and support the polyphenols as potential candidates f
Like
Comment
Share
